Both in Pharmaceuticals
TransCode Therapeutics vs ABVC BioPharma
Over the past year RNAZ returned −83.2% and ABVC returned −64.5%; their daily moves had a correlation of 0.02.
RNAZ −83.2% ABVC −64.5%Growth of $1, one year, split-adjusted
| Metric | RNAZ | ABVC |
|---|---|---|
| Price | $1.60 | $1.00 |
| Market cap | $27.1M | $26.7M |
| Today | +1.91% | +1.51% |
| 1 month | −10.1% | +3.1% |
| 6 months | −78.7% | −9.1% |
| Year to date | −76.6% | −53.1% |
| 1 year | — | −66.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | $34.9K |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 77.7% |
| Short % of float | 8.1% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).